CONVERGE: Management of the multimorbid T2D patient

The CONVERGE educational meeting will be presented by Prof Sham Acharya, Director of Endocrinology and Diabetes JHH and Prof Bobby Chacko Director of Nephrology JHH. It has been developed to reinforce your knowledge of managing cardio-renal-metabolic conditions in patients with T2D. This is your opportunity to learn from the experts as you discuss the management of clinical case studies with your peers.

By the end of this meeting, you will be able to:

- Identify and screen appropriate patients for CKD according to the latest clinical guideline recommendations, including the importance of the urine albumin: creatinine ratio

- Implement a patient-centred approach to CKD management in the context of T2D Identify and screen appropriate patients for CKD according to the latest clinical guideline recommendations, including the importance of the urine albumin: creatinine ratio.

- Refute some common myths about SGLT2 inhibitors